Search

Your search keyword '"Al-Hillawi, Lulia"' showing total 15 results
Start Over Author "Al-Hillawi, Lulia"
15 results on '"Al-Hillawi, Lulia"'

1. Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis

Author

Bird-Lieberman, Elizabeth, Fourie, Simona, Johnston, Richard, Joshi, Heman, Mujamdar, Debabrata, Panter, Simon, Patodi, Nishant, Shaji, Sebastian, Tidbury, Jude, Verma, Ajay, Gupta, Tarun, Antanaviciute, Agne, Hyun-Jung Lee, Chloe, Ottakandathil Babu, Rosana, Aulicino, Anna, Christoforidou, Zoe, Siejka-Zielinska, Paulina, O’Brien-Ball, Caitlin, Chen, Hannah, Fawkner-Corbett, David, Geros, Ana Sousa, Bridges, Esther, McGregor, Colleen, Cianci, Nicole, Fryer, Eve, Alham, Nasullah Khalid, Jagielowicz, Marta, Santos, Ana Mafalda, Fellermeyer, Martin, Davis, Simon J., Parikh, Kaushal, Cheung, Vincent, Al-Hillawi, Lulia, Sasson, Sarah, Slevin, Stephanie, Brain, Oliver, Fernandes, Ricardo A., Koohy, Hashem, and Simmons, Alison

Published
2024
Full Text
View/download PDF

2. Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis

Author

Gupta, Tarun, primary, Antanaviciute, Agne, additional, Hyun-Jung Lee, Chloe, additional, Ottakandathil Babu, Rosana, additional, Aulicino, Anna, additional, Christoforidou, Zoe, additional, Siejka-Zielinska, Paulina, additional, O’Brien-Ball, Caitlin, additional, Chen, Hannah, additional, Fawkner-Corbett, David, additional, Geros, Ana Sousa, additional, Bridges, Esther, additional, McGregor, Colleen, additional, Cianci, Nicole, additional, Fryer, Eve, additional, Alham, Nasullah Khalid, additional, Jagielowicz, Marta, additional, Santos, Ana Mafalda, additional, Fellermeyer, Martin, additional, Davis, Simon J., additional, Parikh, Kaushal, additional, Cheung, Vincent, additional, Al-Hillawi, Lulia, additional, Sasson, Sarah, additional, Slevin, Stephanie, additional, Brain, Oliver, additional, Bird-Lieberman, Elizabeth, additional, Fourie, Simona, additional, Johnston, Richard, additional, Joshi, Heman, additional, Mujamdar, Debabrata, additional, Panter, Simon, additional, Patodi, Nishant, additional, Shaji, Sebastian, additional, Tidbury, Jude, additional, Verma, Ajay, additional, Fernandes, Ricardo A., additional, Koohy, Hashem, additional, and Simmons, Alison, additional

Published
2024
Full Text
View/download PDF

3. Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis

Author

Sasson, Sarah C., Slevin, Stephanie M., Cheung, Vincent T.F., Nassiri, Isar, Olsson-Brown, Anna, Fryer, Eve, Ferreira, Ricardo C., Trzupek, Dominik, Gupta, Tarun, Al-Hillawi, Lulia, Issaias, Mari-lenna, Easton, Alistair, Campo, Leticia, FitzPatrick, Michael E.B., Adams, Joss, Chitnis, Meenali, Protheroe, Andrew, Tuthill, Mark, Coupe, Nicholas, Simmons, Alison, Payne, Miranda, Middleton, Mark R., Travis, Simon P.L., Fairfax, Benjamin P., Klenerman, Paul, and Brain, Oliver

Published
2021
Full Text
View/download PDF

4. Cancer Biology or Ineffective Surveillance? A Multicentre Retrospective Analysis of Colitis-Associated Post-Colonoscopy Colorectal Cancers.

Author

Kabir, Misha, Thomas-Gibson, Siwan, Ahmad, Ahmir, Kader, Rawen, Al-Hillawi, Lulia, Mcguire, Joshua, David, Lewis, Shah, Krishna, Rao, Rohit, Vega, Roser, East, James E, Faiz, Omar D, Hart, Ailsa L, and Wilson, Ana

Abstract

Background and Aims Inflammatory bowel disease [IBD] is associated with high rates of post-colonoscopy colorectal cancer [PCCRC], but further in-depth qualitative analyses are required to determine whether they result from inadequate surveillance or aggressive IBD cancer evolution. Methods All IBD patients who had a colorectal cancer [CRC] diagnosed between January 2015 and July 2019 and a recent [<4 years] surveillance colonoscopy at one of four English hospital trusts underwent root cause analyses as recommended by the World Endoscopy Organisation to identify plausible PCCRC causative factors. Results In total, 61% [ n  = 22/36] of the included IBD CRCs were PCCRCs. They developed in patients with high cancer risk factors [77.8%; n  = 28/36] requiring annual surveillance, yet 57.1% [ n  = 20/35] had inappropriately delayed surveillance. Most PCCRCs developed in situations where [i] an endoscopically unresectable lesion was detected [40.9%; n  = 9/22], [ii] there was a deviation from the planned management pathway [40.9%; n  = 9/22], such as service-, clinician- or patient-related delays in acting on a detected lesion, or [iii] lesions were potentially missed as they were typically located within areas of active inflammation or post-inflammatory change [36.4%; n  = 8/22]. Conclusions IBD PCCRC prevention will require more proactive strategies to reduce endoscopic inflammatory burden, and to improve lesion optical characterization, adherence to recommended surveillance intervals, and patient acceptance of prophylactic colectomy. However, the significant proportion appearing to originate from non-adenomatous-looking mucosa which fail to yield neoplasia on biopsy yet display aggressive cancer evolution highlights the limitations of current surveillance. Emerging molecular biomarkers may play a role in enhancing cancer risk stratification in future clinical practice. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. A ‘real‐world’ retrospective multi‐centre cohort study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis

Author

Kronsten, Victoria Tatiana, primary, Colwill, Michael J., additional, Nayeemuddin, Shadab, additional, Limdi, Jimmy K., additional, Selinger, Christian, additional, Scott, Glyn, additional, Al‐Hillawi, Lulia, additional, Salehi, Shayon, additional, Blaker, Paul, additional, Chung‐Faye, Guy, additional, Kent, Alexandra J., additional, Dubois, Patrick, additional, and Hayee, Bu, additional

Published
2021
Full Text
View/download PDF

12. PTU-007 A retrospective multicentre study comparing infliximab and adalimumab for maintenance of remission in ulcerative colitis

Author

Kronsten, Victoria, primary, Colwill, Michael, additional, Nayeemuddin, Shadab, additional, Limdi, Jimmy, additional, Selinger, Christian, additional, Scott, Glyn, additional, Al-Hillawi, Lulia, additional, Salehi, Shayon, additional, Blaker, Paul, additional, Chung-Faye, Guy, additional, Kent, Alexandra, additional, Dubois, Patrick, additional, and Hayee, Bu, additional

Published
2018
Full Text
View/download PDF

14. Mo1878 - A ‘Real World’ Retrospective Multicentre Study Comparing Infliximab and Adalimumab for the Maintenance of Remission in Ulcerative Colitis

Author

Kronsten, Victoria T., primary, Colwill, Michael, additional, Nayeemuddin, Shadab, additional, Limdi, Jimmy K., additional, Selinger, Christian P., additional, Scott, Glyn, additional, Al-Hillawi, Lulia, additional, Salehi, Shayon, additional, Blaker, Paul, additional, Chung-Faye, Guy, additional, Kent, Alexandra, additional, Dubois, Patrick, additional, and Hayee, Bu, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results